Annual EBIT
-$369.00 M
-$774.00 M-191.11%
December 31, 2024
Summary
- As of February 6, 2025, TEVA annual earnings before interest & taxes is -$369.00 million, with the most recent change of -$774.00 million (-191.11%) on December 31, 2024.
- During the last 3 years, TEVA annual EBIT has fallen by -$1.92 billion (-123.82%).
- TEVA annual EBIT is now -109.37% below its all-time high of $3.94 billion, reached on December 31, 2014.
Performance
TEVA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$23.00 M
+$29.00 M+55.77%
December 31, 2024
Summary
- As of February 6, 2025, TEVA quarterly earnings before interest & taxes is -$23.00 million, with the most recent change of +$29.00 million (+55.77%) on December 31, 2024.
- Over the past year, TEVA quarterly EBIT has increased by +$194.00 million (+89.40%).
- TEVA quarterly EBIT is now -101.51% below its all-time high of $1.52 billion, reached on March 31, 2018.
Performance
TEVA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$297.00 M
-$751.00 M-165.42%
December 31, 2024
Summary
- As of February 6, 2025, TEVA TTM earnings before interest & taxes is -$297.00 million, with the most recent change of -$751.00 million (-165.42%) on December 31, 2024.
- Over the past year, TEVA TTM EBIT has dropped by -$497.00 million (-248.50%).
- TEVA TTM EBIT is now -107.54% below its all-time high of $3.94 billion, reached on December 31, 2014.
Performance
TEVA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TEVA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -191.1% | +89.4% | -248.5% |
| 3 y3 years | -123.8% | +97.6% | +73.7% |
| 5 y5 years | +16.7% | -104.9% | +91.5% |
TEVA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -123.8% | +83.5% | -103.2% | +97.7% | -119.2% | +86.7% |
| 5 y | 5-year | -123.8% | +89.5% | -103.2% | +99.5% | -114.1% | +92.3% |
| alltime | all time | -109.4% | +97.9% | -101.5% | +99.8% | -107.5% | +98.3% |
Teva Pharmaceutical Industries Limited EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$369.00 M(-191.1%) | -$23.00 M(-55.8%) | -$297.00 M(-165.4%) |
| Sep 2024 | - | -$52.00 M(+940.0%) | $454.00 M(-46.6%) |
| Jun 2024 | - | -$5.00 M(-97.7%) | $850.00 M(+325.0%) |
| Mar 2024 | - | -$217.00 M(-129.8%) | $200.00 M(-50.6%) |
| Dec 2023 | $405.00 M(-118.1%) | $728.00 M(+111.6%) | $405.00 M(-130.8%) |
| Sep 2023 | - | $344.00 M(-152.5%) | -$1.31 B(+6.0%) |
| Jun 2023 | - | -$655.00 M(+5358.3%) | -$1.24 B(-19.2%) |
| Mar 2023 | - | -$12.00 M(-98.8%) | -$1.53 B(-31.4%) |
| Dec 2022 | -$2.23 B(-244.2%) | -$990.00 M(-336.8%) | -$2.23 B(+67.6%) |
| Sep 2022 | - | $418.00 M(-144.0%) | -$1.33 B(+18.2%) |
| Jun 2022 | - | -$949.00 M(+33.1%) | -$1.13 B(-379.9%) |
| Mar 2022 | - | -$713.00 M(+701.1%) | $403.00 M(-74.0%) |
| Dec 2021 | $1.55 B(-144.2%) | -$89.00 M(-114.3%) | $1.55 B(-26.6%) |
| Sep 2021 | - | $623.00 M(+7.0%) | $2.11 B(-174.0%) |
| Jun 2021 | - | $582.00 M(+34.1%) | -$2.85 B(-12.6%) |
| Mar 2021 | - | $434.00 M(-8.2%) | -$3.26 B(-6.9%) |
| Dec 2020 | -$3.50 B(+691.2%) | $473.00 M(-110.9%) | -$3.51 B(-8.5%) |
| Sep 2020 | - | -$4.34 B(-2624.4%) | -$3.83 B(-990.9%) |
| Jun 2020 | - | $172.00 M(-9.9%) | $430.00 M(-211.4%) |
| Mar 2020 | - | $191.00 M(+29.1%) | -$386.00 M(-12.9%) |
| Dec 2019 | -$443.00 M(-73.6%) | $148.00 M(-282.7%) | -$443.00 M(-88.3%) |
| Sep 2019 | - | -$81.00 M(-87.4%) | -$3.79 B(+2.6%) |
| Jun 2019 | - | -$644.00 M(-580.6%) | -$3.70 B(+20.5%) |
| Mar 2019 | - | $134.00 M(-104.2%) | -$3.07 B(+83.0%) |
| Dec 2018 | -$1.68 B(-90.4%) | -$3.20 B(<-9900.0%) | -$1.68 B(-85.4%) |
| Sep 2018 | - | $16.00 M(-214.3%) | -$11.51 B(+3.2%) |
| Jun 2018 | - | -$14.00 M(-100.9%) | -$11.15 B(-33.9%) |
| Mar 2018 | - | $1.52 B(-111.7%) | -$16.87 B(-3.6%) |
| Dec 2017 | -$17.50 B(-1377.7%) | -$13.04 B(-3548.9%) | -$17.50 B(+224.9%) |
| Sep 2017 | - | $378.00 M(-106.6%) | -$5.39 B(+7.7%) |
| Jun 2017 | - | -$5.74 B(-741.3%) | -$5.00 B(-554.6%) |
| Mar 2017 | - | $895.00 M(-197.2%) | $1.10 B(-19.7%) |
| Dec 2016 | $1.37 B(-47.7%) | -$921.00 M(-220.4%) | $1.37 B(-45.0%) |
| Sep 2016 | - | $765.00 M(+111.9%) | $2.49 B(-9.0%) |
| Jun 2016 | - | $361.00 M(-69.0%) | $2.74 B(-9.9%) |
| Mar 2016 | - | $1.17 B(+479.6%) | $3.04 B(+15.9%) |
| Dec 2015 | $2.62 B(-33.4%) | $201.00 M(-80.1%) | $2.62 B(-21.7%) |
| Sep 2015 | - | $1.01 B(+52.6%) | $3.35 B(-3.0%) |
| Jun 2015 | - | $662.00 M(-11.6%) | $3.45 B(-7.1%) |
| Mar 2015 | - | $749.00 M(-19.4%) | $3.71 B(-5.7%) |
| Dec 2014 | $3.94 B(+151.8%) | $929.00 M(-16.5%) | $3.94 B(+13.0%) |
| Sep 2014 | - | $1.11 B(+20.2%) | $3.48 B(+9.8%) |
| Jun 2014 | - | $925.00 M(-4.8%) | $3.17 B(+90.9%) |
| Mar 2014 | - | $972.00 M(+104.6%) | $1.66 B(+6.3%) |
| Dec 2013 | $1.56 B(-28.1%) | $475.00 M(-40.7%) | $1.56 B(+12.7%) |
| Sep 2013 | - | $801.00 M(-236.7%) | $1.39 B(+163.4%) |
| Jun 2013 | - | -$586.00 M(-167.0%) | $527.00 M(-75.1%) |
| Mar 2013 | - | $874.00 M(+192.3%) | $2.12 B(-2.5%) |
| Dec 2012 | $2.17 B(-31.8%) | $299.00 M(-598.3%) | $2.17 B(-15.3%) |
| Sep 2012 | - | -$60.00 M(-106.0%) | $2.57 B(-29.9%) |
| Jun 2012 | - | $1.01 B(+8.5%) | $3.66 B(+3.9%) |
| Mar 2012 | - | $928.00 M(+34.3%) | $3.52 B(+1.8%) |
| Dec 2011 | $3.19 B(-17.1%) | $691.00 M(-33.2%) | $3.46 B(-1.7%) |
| Sep 2011 | - | $1.03 B(+19.1%) | $3.52 B(-4.2%) |
| Jun 2011 | - | $869.00 M(+0.2%) | $3.67 B(-5.3%) |
| Mar 2011 | - | $867.00 M(+15.4%) | $3.88 B(+0.9%) |
| Dec 2010 | $3.85 B(+60.0%) | $751.00 M(-36.8%) | $3.85 B(+9.7%) |
| Sep 2010 | - | $1.19 B(+10.5%) | $3.51 B(+14.2%) |
| Jun 2010 | - | $1.07 B(+28.9%) | $3.07 B(+13.8%) |
| Mar 2010 | - | $834.00 M(+102.4%) | $2.70 B(+12.3%) |
| Dec 2009 | $2.40 B(+110.0%) | $412.00 M(-45.3%) | $2.40 B(+105.4%) |
| Sep 2009 | - | $753.00 M(+7.3%) | $1.17 B(+9.6%) |
| Jun 2009 | - | $702.00 M(+30.5%) | $1.07 B(+6.4%) |
| Mar 2009 | - | $538.00 M(-165.5%) | $1.00 B(-12.3%) |
| Dec 2008 | $1.15 B(-52.2%) | -$822.00 M(-226.5%) | $1.15 B(-56.4%) |
| Sep 2008 | - | $650.00 M(+1.9%) | $2.63 B(-0.0%) |
| Jun 2008 | - | $638.00 M(-6.0%) | $2.63 B(+0.0%) |
| Mar 2008 | - | $679.00 M(+2.7%) | $2.63 B(+9.7%) |
| Dec 2007 | $2.40 B(+14.3%) | $661.00 M(+1.5%) | $2.40 B(+11.0%) |
| Sep 2007 | - | $651.00 M(+2.2%) | $2.16 B(-3.3%) |
| Jun 2007 | - | $637.00 M(+42.8%) | $2.23 B(-1.7%) |
| Mar 2007 | - | $446.00 M(+5.5%) | $2.27 B(+6.6%) |
| Dec 2006 | $2.10 B(+59.8%) | $422.80 M(-41.6%) | $2.13 B(+3.0%) |
| Sep 2006 | - | $723.60 M(+7.2%) | $2.07 B(+24.9%) |
| Jun 2006 | - | $675.20 M(+120.7%) | $1.65 B(+28.5%) |
| Mar 2006 | - | $306.00 M(-15.1%) | $1.29 B(-1.9%) |
| Dec 2005 | $1.31 B | $360.30 M(+15.4%) | $1.31 B(+1.9%) |
| Sep 2005 | - | $312.20 M(+1.2%) | $1.29 B(-0.4%) |
| Jun 2005 | - | $308.60 M(-6.7%) | $1.29 B(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | $330.90 M(-1.5%) | $1.28 B(+9.1%) |
| Dec 2004 | $1.18 B(+32.8%) | $336.00 M(+5.8%) | $1.18 B(+10.3%) |
| Sep 2004 | - | $317.70 M(+6.9%) | $1.07 B(+12.8%) |
| Jun 2004 | - | $297.10 M(+32.5%) | $944.90 M(+1.6%) |
| Mar 2004 | - | $224.20 M(-1.0%) | $929.70 M(+5.1%) |
| Dec 2003 | $884.80 M(+68.9%) | $226.50 M(+14.9%) | $884.80 M(+5.2%) |
| Sep 2003 | - | $197.10 M(-30.1%) | $840.90 M(+9.9%) |
| Jun 2003 | - | $281.90 M(+57.2%) | $765.40 M(+28.6%) |
| Mar 2003 | - | $179.30 M(-1.8%) | $595.10 M(+13.6%) |
| Dec 2002 | $524.00 M(+39.2%) | $182.60 M(+50.2%) | $524.00 M(+15.6%) |
| Sep 2002 | - | $121.60 M(+9.0%) | $453.16 M(+5.2%) |
| Jun 2002 | - | $111.60 M(+3.1%) | $430.56 M(+6.1%) |
| Mar 2002 | - | $108.20 M(-3.2%) | $405.81 M(+7.8%) |
| Dec 2001 | $376.46 M(+0.3%) | $111.76 M(+12.9%) | $376.51 M(-14.6%) |
| Sep 2001 | - | $99.00 M(+14.0%) | $440.71 M(+5.9%) |
| Jun 2001 | - | $86.85 M(+10.1%) | $416.13 M(+4.5%) |
| Mar 2001 | - | $78.90 M(-55.2%) | $398.12 M(+6.1%) |
| Dec 2000 | $375.21 M(+40.3%) | $175.95 M(+136.4%) | $375.21 M(+13.9%) |
| Sep 2000 | - | $74.42 M(+8.1%) | $329.32 M(+7.4%) |
| Jun 2000 | - | $68.84 M(+22.9%) | $306.55 M(+8.5%) |
| Mar 2000 | - | $56.00 M(-56.9%) | $282.45 M(+5.6%) |
| Dec 1999 | $267.47 M(+31.3%) | $130.07 M(+151.9%) | $267.37 M(+10.5%) |
| Sep 1999 | - | $51.64 M(+15.4%) | $241.94 M(+5.2%) |
| Jun 1999 | - | $44.74 M(+9.3%) | $229.99 M(+10.1%) |
| Mar 1999 | - | $40.92 M(-60.9%) | $208.85 M(+2.6%) |
| Dec 1998 | $203.73 M(+17.2%) | $104.63 M(+163.6%) | $203.53 M(-136.9%) |
| Sep 1998 | - | $39.70 M(+68.2%) | -$552.30 M(+80.9%) |
| Jun 1998 | - | $23.60 M(-33.7%) | -$305.30 M(+424.5%) |
| Mar 1998 | - | $35.60 M(-105.5%) | -$58.20 M(-133.5%) |
| Dec 1997 | $173.80 M(+34.4%) | -$651.20 M(-327.1%) | $173.80 M(-37.5%) |
| Sep 1997 | - | $286.70 M(+5.9%) | $278.20 M(+22.0%) |
| Jun 1997 | - | $270.70 M(+1.2%) | $228.10 M(+9.9%) |
| Mar 1997 | - | $267.60 M(-148.9%) | $207.60 M(+60.6%) |
| Dec 1996 | $129.30 M(+24.1%) | -$546.80 M(-331.1%) | $129.30 M(-57.7%) |
| Sep 1996 | - | $236.60 M(-5.4%) | $305.50 M(+30.4%) |
| Jun 1996 | - | $250.20 M(+32.2%) | $234.20 M(+66.3%) |
| Mar 1996 | - | $189.30 M(-151.1%) | $140.80 M(+35.1%) |
| Dec 1995 | $104.20 M(+0.7%) | -$370.60 M(-324.2%) | $104.20 M(-31.1%) |
| Sep 1995 | - | $165.30 M(+5.4%) | $151.20 M(+16.8%) |
| Jun 1995 | - | $156.80 M(+2.7%) | $129.40 M(+8.3%) |
| Mar 1995 | - | $152.70 M(-147.2%) | $119.50 M(+15.5%) |
| Dec 1994 | $103.50 M(+17.6%) | -$323.60 M(-325.5%) | $103.50 M(-28.3%) |
| Sep 1994 | - | $143.50 M(-2.3%) | $144.40 M(+12.7%) |
| Jun 1994 | - | $146.90 M(+7.5%) | $128.10 M(+20.6%) |
| Mar 1994 | - | $136.70 M(-148.4%) | $106.20 M(+20.8%) |
| Dec 1993 | $88.00 M(+60.9%) | -$282.70 M(-322.2%) | $87.90 M(-41.6%) |
| Sep 1993 | - | $127.20 M(+1.8%) | $150.50 M(+29.4%) |
| Jun 1993 | - | $125.00 M(+5.6%) | $116.30 M(+38.0%) |
| Mar 1993 | - | $118.40 M(-153.8%) | $84.30 M(+43.4%) |
| Dec 1992 | $54.70 M(+5.0%) | -$220.10 M(-336.7%) | $58.80 M(-32.1%) |
| Sep 1992 | - | $93.00 M(0.0%) | $86.60 M(+19.8%) |
| Jun 1992 | - | $93.00 M(+0.1%) | $72.30 M(+26.6%) |
| Mar 1992 | - | $92.90 M(-148.3%) | $57.10 M(+10.9%) |
| Dec 1991 | $52.10 M(+29.3%) | -$192.30 M(-344.3%) | $51.50 M(-45.8%) |
| Sep 1991 | - | $78.70 M(+1.2%) | $95.00 M(+20.4%) |
| Jun 1991 | - | $77.80 M(-10.9%) | $78.90 M(+11.6%) |
| Mar 1991 | - | $87.30 M(-158.7%) | $70.70 M(+44.0%) |
| Dec 1990 | $40.30 M(-8.8%) | -$148.80 M(-337.7%) | $49.10 M(+6.0%) |
| Sep 1990 | - | $62.60 M(-10.1%) | $46.30 M(-2.5%) |
| Jun 1990 | - | $69.60 M(+5.9%) | $47.50 M(+1.7%) |
| Mar 1990 | - | $65.70 M(-143.3%) | $46.70 M(-5.1%) |
| Dec 1989 | $44.20 M(+96.4%) | -$151.60 M(-337.6%) | $49.20 M(-37.4%) |
| Sep 1989 | - | $63.80 M(-7.3%) | $78.60 M(+28.0%) |
| Jun 1989 | - | $68.80 M(+0.9%) | $61.40 M(+43.8%) |
| Mar 1989 | - | $68.20 M(-155.8%) | $42.70 M(+74.3%) |
| Dec 1988 | $22.50 M(+16.6%) | -$122.20 M(-362.2%) | $24.50 M(-83.3%) |
| Sep 1988 | - | $46.60 M(-7.0%) | $146.70 M(+14.1%) |
| Jun 1988 | - | $50.10 M(+0.2%) | $128.60 M(+22.6%) |
| Mar 1988 | - | $50.00 M(+75.4%) | $104.90 M(+2284.1%) |
| Sep 1987 | - | $28.50 M(+8.0%) | $4.40 M(-59.3%) |
| Jun 1987 | - | $26.40 M(-130.9%) | $10.80 M(-44.0%) |
| Mar 1987 | $19.30 M(+62.2%) | -$85.40 M(-344.7%) | $19.30 M(-60.0%) |
| Dec 1986 | - | $34.90 M(0.0%) | $48.20 M(+33.5%) |
| Sep 1986 | - | $34.90 M(0.0%) | $36.10 M(+50.4%) |
| Jun 1986 | - | $34.90 M(-161.8%) | $24.00 M(+101.7%) |
| Mar 1986 | $11.90 M | -$56.50 M(-347.8%) | $11.90 M(-82.6%) |
| Dec 1985 | - | $22.80 M(0.0%) | $68.40 M(+50.0%) |
| Sep 1985 | - | $22.80 M(0.0%) | $45.60 M(+100.0%) |
| Jun 1985 | - | $22.80 M | $22.80 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual earnings before interest & taxes?
- What is the all time high annual EBIT for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual EBIT year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly EBIT year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM EBIT year-on-year change?
What is Teva Pharmaceutical Industries Limited annual earnings before interest & taxes?
The current annual EBIT of TEVA is -$369.00 M
What is the all time high annual EBIT for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual earnings before interest & taxes is $3.94 B
What is Teva Pharmaceutical Industries Limited annual EBIT year-on-year change?
Over the past year, TEVA annual earnings before interest & taxes has changed by -$774.00 M (-191.11%)
What is Teva Pharmaceutical Industries Limited quarterly earnings before interest & taxes?
The current quarterly EBIT of TEVA is -$23.00 M
What is the all time high quarterly EBIT for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly earnings before interest & taxes is $1.52 B
What is Teva Pharmaceutical Industries Limited quarterly EBIT year-on-year change?
Over the past year, TEVA quarterly earnings before interest & taxes has changed by +$194.00 M (+89.40%)
What is Teva Pharmaceutical Industries Limited TTM earnings before interest & taxes?
The current TTM EBIT of TEVA is -$297.00 M
What is the all time high TTM EBIT for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM earnings before interest & taxes is $3.94 B
What is Teva Pharmaceutical Industries Limited TTM EBIT year-on-year change?
Over the past year, TEVA TTM earnings before interest & taxes has changed by -$497.00 M (-248.50%)